Clinical Trial Update: Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating donepezil hydrochloride (E2020) for dementia associated with cerebrovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Aricept (Donepezil)

Snippet

Sponsor: Eisai Inc. | Conditions: Dementia, Vascular | Phase 3 | Status: COMPLETED